Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Teyi Pharmaceutical Group
Taishan, Guangdong, China
- Ownership
- Private
- Employees
- ~1341
- Development stage
- Other
01
Overview
Teyi Pharmaceutical focuses on commercial production of generic drugs and traditional Chinese medicines; the approved product 'ZhiKeBao' is indicated for the common cold. The company has recent bioequivalence studies for diclofenac sodium and doxycycline hydrochloride tablets.[3]
- Therapeutic areas
- Infectious DiseasesPulmonology
- Modalities
- Small moleculeHerbal medicine
- Industry
- Biotech
02
Partnerships
Hainan Haili Pharmaceutical Co. Ltd.
Beyond the preview
Go deeper on Teyi Pharmaceutical Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Teyi Pharmaceutical Group.